Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
BILTHOVEN, the Netherlands, July 30, 2014 /PRNewswire/ --
Dutch market research panel 'hettestpanel.nl' tested Gladskin Skin Irritation on a large group of men and women suffering from skin irritation after shaving. Gladskin's scientific approach yields exceptionally high scores, with an 80% score on efficacy and 91% on user satisfaction.
Gladskin Skin Irritation targets only the bacteria that cause or worsen the majority of all skin infections: Staphylococcus aureus. Shaving irritation is almost always caused by this bacterial species. Exposure to Staphylococcus aureus is practically unavoidable. What distinguishes Gladskin is that it kills only Staphylococcus aureus yet leaves the good bacteria - essential for a healthy skin - intact. This is a world first. These results were also published at the recent European Congress of Clinical Microbiology and Infectious Diseases in Barcelona.
Less irritation after shaving
Shaving armpits, bikini line, legs and facial hair often causes minuscule wounds. These offer an ideal setting for Staphylococcus aureus bacteria to cause infections. This 'shaving irritation' is characterized by redness, pimples, shaving bumps and an itching and burning sensation. Many people suffer from this problem. Now, for the first time, the actual cause of this problem can be targeted. This marks a scientific breakthrough. Antibiotics and other traditional anti-bacterial products do not distinguish between good and bad bacteria. Recent publications support that a healthy bacterial population is far more important for a healthy skin than previously assumed.
Micreos (micreos.com) is a Dutch biotechnology company with research and production centres in Wageningen and Bilthoven, and headquarters in The Hague. The company collaborates with numerous institutes and universities, including the Swiss Federal Technology Institute in Zurich, Erasmus Medical Centre in Rotterdam, the University Medical Centre Utrecht and TNO.
Micreos is specialised in the development of products against unwanted bacteria and is regarded as a global leader in this field. The company aims to replace antibiotics with its anti-bacterial technology in many areas.
Gladskin is a Micreos Human Health brand focusing on the development of hypoallergenic products for skin problems with an infectious component. Gladskin Acne, Eczema, Rosacea and Skin Irritation are available in all Dutch pharmacies and can be ordered throughout Europe, prescription-free, at Gladskin.com. Micreos has also developed SALMONELEX™ against Salmonella - recently FDA approved - and LISTEX™ against Listeria.
©2012 PR Newswire. All Rights Reserved.